Skip to content

Fighting to Preserve the Benefits of the 340B Program

  • About Us
  • Contact Us
Top Bar Menu
Facebook page opens in new windowTwitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
    • Webinars
  • News
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
    • Webinars
  • News

pexels pixabay 48195

HRSA Informs Six Manufacturers That Their Contract Pharmacy Policies Violate the 340B Statute

Drug Pricing, HHS, HRSA, News, RWC-340BBy adminMay 18, 2021

Yesterday, HRSA Acting Administrator Diana Espinosa sent letters to Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi, and United Therapeutics making clear to the manufacturers that their restrictions on access to…

226 Members of Congress Call on HHS Secretary to Protect 340B Program

Congress, Drug Pricing, HHS, HIV/AIDS, NewsBy adminMarch 2, 2021

Representative Spanberger issued a press release yesterday announcing that she and 225 of her colleagues sent a letter to Acting HHS Secretary Norris Cochran, asking HHS to take immediate action…

Novo Nordisk and United Therapeutics Are the Latest Drug Manufacturers to Limit Access to 340B Prices at Contract Pharmacies

Drug Pricing, News, RWC-340BBy adminDecember 3, 2020

On December 1, 2020, drug manufacturer Novo Nordisk Inc. announced that, effective January 1, 2021, it “will no longer facilitate ‘bill-to/ship-to’ distribution of 340B product to a contract pharmacy of…

Press Release: RWC-340B and 340B Covered Entity Plaintiffs Ask Secretary of HHS to Immediately Enforce Covered Entities’ Rights Under 340B Statute

Drug Pricing, HHS, HRSABy adminNovember 24, 2020

Washington, D.C. – On November 23, 2020, Ryan White Clinics for 340B Access (RWC-340B) and five 340B providers filed a motion in the United States District Court for the District…

217 Congressional Representatives Send Letter to Secretary Azar Opposing the Kalderos Rebate Model

Congress, Drug Pricing, News, RWC-340BBy adminNovember 13, 2020

Thanks to efforts by RWC-340B members and other covered entity advocates, 217 members of the House of Representatives signed a bipartisan letter to Health and Human Services (HHS) Secretary Alex…

Novartis Takes a Less Restrictive Approach to 340B Pricing at Contract Pharmacies

Drug Pricing, News, RWC-340BBy adminNovember 2, 2020

By letter dated October 30, 2020, Novartis is notifying covered entities that are federal grantees that they will continue to receive 340B discounts at contract pharmacies and, beginning November 16,…

RWC-340B and 340B Grantee Plaintiffs File Lawsuit Against HHS/HRSA to Protect 340B Contract Pharmacy Program from Manufacturer Attacks

Drug Pricing, HHS, News, RWC-340BBy adminOctober 12, 2020

On October 9, 2020, RWC-340B and two of its member 340B grantee clinics, Cempa Community Cares and Matthew 25 AIDS Services, Inc., filed a lawsuit in the United States District…

RWC-340B Submits Letter to HHS Regarding Drug Manufacturers Actions That Undermine the 340B Program & Letter to HRSA Regarding 340B Telehealth Policies

Congress, Drug Pricing, HHS, News, RWC-340BBy adminSeptember 11, 2020

Today, RWC-340B submitted to a letter to Secretary of the U.S. Department of Health and Human Services (HHS) Alex Azar requesting that HHS initiate enforcement actions, in the form of…

Eli Lilly Announces New Limited Distribution Plan

Drug Pricing, News, RWC-340BBy adminSeptember 1, 2020

In a notice sent to covered entities and other 340B program participants, Eli Lilly and Co. (Lilly) announced that, effective September 1, 2020, it is implementing a limited distribution plan…

Recap of Second 340B ESP™ Basic User Training Webinar

Drug Pricing, News, RWC-340BBy adminAugust 28, 2020

On August 26, Second Sight Solutions, the owner of the 340B ESP™ platform, hosted the second in a series of webinars on 340B ESP™.  The webinar, entitled Data Security, Privacy,…

←1
2
…34567…
8910111213
14→
                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset